Cigna Corp
XHAM:CGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Cigna Corp (CGN) under the Base Case is 494.84 EUR per share.
Compared with the current market price of 267.5 EUR, the stock appears
Undervalued by 46% .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Cigna Does
Cigna is a health services company that helps people and organizations pay for and manage medical care. It sells health insurance and related benefit plans to employers, government programs, and some individual customers. It also provides pharmacy benefit management, which means it helps clients handle prescription drug coverage, claims, and drug spending.
- Headquarters
- United States of America US
- Employees
- 73 700
- IPO date
- Apr 1, 1982
Cigna has a narrow economic moat
Buying medicines for a large customer base helps Cigna negotiate discounts that smaller competitors struggle to match. Its work handling benefit rules, patient information and claims also makes replacing it a substantial task for employers and health plans, giving established relationships staying power. These advantages offer protection mainly against smaller challengers rather than similarly large rivals.
Read the full moat analysisWhat is the Intrinsic Value of one CGN stock?
The intrinsic value for Cigna Corp (CGN) under the Base Case is 494.84 EUR.
Is CGN stock undervalued or overvalued?
Compared with the current market price of 267.5 EUR, the stock appears Undervalued by 46% .
